NCT00870077

A Pilot Study on Whey Protein Supplementation in Non Alcoholic Fatty Liver Disease

Effect of a Whey Protein Supplementation on Intrahepatic Lipids in Obese Patients With Non-alcoholic Fatty Liver Disease

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 11 (actual)
• Sponsor: University of Lausanne · Academic / Other
• Sex: All
• Age: 18 Years – 50 Years
• Healthy volunteers: Not accepted

Summary

An increase in dietary protein intake has been shown to blunt the increase in intrahepatic fat induced by high fat feeding in healthy individuals. The purpose of this study is to determine if a protein supplementation decreases intrahepatic fat in obese patients with non-alcoholic fatty liver disease.

Detailed description

12 obese patients will be be treated with a dietary whey protein supplementation over 4 weeks. Their intrahepatic fat content, glucose tolerance, and body weight will be evaluated before and after 4 weeks of supplementation.

Conditions

• Non-alcoholic Fatty Liver Disease
• Obesity

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	ProWHEY 94 CFM, SponserR	3 times 20g per day

Timeline

• Start date: 2009-04-01
• Primary completion: 2009-12-01
• Completion: 2010-04-01
• First posted: 2009-03-26
• Last updated: 2012-02-24

Locations

1 site across 1 country: Switzerland